Abstract:Magdalini Tsintou, Kyriakos Dalamagkas, Nikos Makris Neural Regeneration Research 2020 15(3):425-437 The central nervous system is known to have limited regenerative capacity. Not only does this halt the human body’s reparative processes after central nervous system lesions, but it also impedes the establishment of effective and safe therapeutic options for such patients. Despite the high prevalence of stroke and spinal cord injury in the general population, these conditions remain incurable and place a heavy burden on patients’ families and on society more broadly. Neuroregeneration and neural engineering are diverse biomedical fields that attempt reparative treatments, utilizing stem cells-based strategies, biologically active molecules, nanotechnology, exosomes and highly tunable biodegradable systems (e.g., certain hydrogels). Although there are studies demonstrating promising preclinical results, safe clinical translation has not yet been accomplished. A key gap in clinical translation is the absence of an ideal animal or ex vivo model that can perfectly simulate the human microenvironment, and also correspond to all the complex pathophysiological and neuroanatomical factors that affect functional outcomes in humans after central nervous system injury. Such an ideal model does not currently exist, but it seems that the nonhuman primate model is uniquely qualified for this role, given its close resemblance to humans. This review considers some regenerative therapies for central nervous system repair that hold promise for future clinical translation. In addition, it attempts to uncover some of the main reasons why clinical translation might fail without the implementation of nonhuman primate models in the research pipeline.

Therapeutic Transplantation of Human Central Nervous System Organoids for Neural Reconstruction

Stem Cells in Central Nervous System Diseases: Promising Therapeutic Strategies.

Three-Dimensional Organoid System Transplantation Technologies in Future Treatment of Central Nervous System Diseases

The Application of Neural Stem/Progenitor Cells for Regenerative Therapy of Spinal Cord Injury

Spinal cord tissue engineering using human primary neural progenitor cells and astrocytes

Neural stem cell therapy for brain disease

Current Challenges for the Advancement of Neural Stem Cell Biology and Transplantation Research

Human Cerebral Organoid Implantation Alleviated the Neurological Deficits of Traumatic Brain Injury in Mice.

Cerebral organoids transplantation repairs infarcted cortex and restores impaired function after stroke

Regenerative Therapies for Central Nervous System Diseases: a Biomaterials Approach

Neuronal Replacement in Stem Cell Therapy for Stroke: Filling the Gap

Neuromodulation-Based Stem Cell Therapy in Brain Repair: Recent Advances and Future Perspectives

Advances of Transplantation of Neural Stem Cells

Generation of Neural Organoids for Spinal-Cord Regeneration Via the Direct Reprogramming of Human Astrocytes

Transplanting neural progenitor cells to restore connectivity after spinal cord injury

Neural stem cell transplantation therapy for brain ischemic stroke: Review and perspectives

[Neural Stem Cells and Human Brain Regeneration Medicine].

Characterization of Human-Induced Neural Stem Cells and Derivatives following Transplantation into the Central Nervous System of a Nonhuman Primate and Rats

Taking central nervous system regenerative therapies to the clinic: curing rodents versus nonhuman primates versus humans

Organoids and chimeras: the hopeful fusion transforming traumatic brain injury research

The Biological Behaviors of Neural Stem Cell Affected by Microenvironment from Host Organotypic Brain Slices under Different Conditions